Therapeutics News and Research

RSS

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Magic mushrooms may not be the answer to postpartum depression, new research from the University of California, Davis suggests.

30 Sep 2025

Tagomics publishes a new approach to genome-wide epigenomic profiling

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced the publication of a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics' Activace™ platform.

30 Sep 2025

Study points toward earlier and more accurate detection of ALS

A new study applying multi-omics techniques and machine learning identified 33 plasma proteins that differ significantly in patients with amyotrophic lateral sclerosis (ALS).

29 Sep 2025

Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.

29 Sep 2025

Engineers create designer biobots using human lung cells

A brand-new engineering approach to generate "designer" biological robots using human lung cells is underway in Carnegie Mellon University's Ren lab.

26 Sep 2025

Optogenetics and artificial intelligence open path to personalized Parkinson’s treatment

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia, and postural instability.

26 Sep 2025

WHO Member States advance negotiations on Pathogens Access and Benefit Sharing system

WHO Member States held their second intergovernmental meeting from 15-19 September, to further develop the Pathogens Access and Benefit Sharing (PABS) system, a critical annex to the WHO Pandemic Agreement.

26 Sep 2025

RION engages Lonza to scale manufacturing exosome based therapeutics

RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived exosomes for both human and animal health applications, has announced a collaboration with Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product™ (PEP™) drug substance for late phase clinical supply and beyond.

From Lonza 26 Sep 2025

Simple tweak to how AI assigns diagnostic codes could improve accuracy

A new study from researchers at the Mount Sinai Health System suggests that a simple tweak to how artificial intelligence (AI) assigns diagnostic codes could significantly improve accuracy, even outperforming physicians.

25 Sep 2025

Mount Sinai study maps protein networks driving Alzheimer’s disease pathogenesis

A new study led by the Icahn School of Medicine at Mount Sinai offers one of the most comprehensive views yet of how brain cells interact in Alzheimer's disease, mapping protein networks that reveal communication failures and point to new therapeutic opportunities.

25 Sep 2025

AstroCapsules offer a new way to reduce brain inflammation

Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease.

25 Sep 2025

Genetic modification enhances "living drugs" for blood cancers

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a "chimeric antigen receptor" (CAR) enables them to specifically recognize and attack cancer cells.

25 Sep 2025

AI-guided platform improves design and efficiency of therapeutic nanoparticles

Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial intelligence (AI) to design nanoparticles for drug delivery.

24 Sep 2025

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

24 Sep 2025

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent, causing severe viral hemorrhagic fever with mortality rates reaching up to 40%.

24 Sep 2025

Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis

Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates and poor prognosis.

23 Sep 2025

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Osteoporosis is a degenerative disease characterized by decreased bone mass and damage to bone microarchitecture, as well as increased bone fragility.

23 Sep 2025

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

18 Sep 2025

New class of antibiotics shows potent activity against multidrug-resistant bacteria

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's most dangerous multidrug-resistant (MDR) bacteria.

18 Sep 2025

POT1 gene mutation linked to pulmonary fibrosis through telomere dysfunction

Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which lung tissue develops scarring and becomes stiff, making breathing increasingly difficult over time.

18 Sep 2025

Therapeutics News and Research

Negative behavioral effects of psilocybin persist in mouse mothers and offspring

Tagomics publishes a new approach to genome-wide epigenomic profiling

Study points toward earlier and more accurate detection of ALS

Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients

Engineers create designer biobots using human lung cells

Optogenetics and artificial intelligence open path to personalized Parkinson’s treatment

WHO Member States advance negotiations on Pathogens Access and Benefit Sharing system

RION engages Lonza to scale manufacturing exosome based therapeutics

Simple tweak to how AI assigns diagnostic codes could improve accuracy

Mount Sinai study maps protein networks driving Alzheimer’s disease pathogenesis

AstroCapsules offer a new way to reduce brain inflammation

Genetic modification enhances "living drugs" for blood cancers

AI-guided platform improves design and efficiency of therapeutic nanoparticles

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis

Targeting miR-378 could offer a dual-action strategy against osteoporosis

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

New class of antibiotics shows potent activity against multidrug-resistant bacteria

POT1 gene mutation linked to pulmonary fibrosis through telomere dysfunction

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News